Fig. 3.

Moderate hyperbilirubinemia attenuates ANG II-dependent hypertension. Mice were treated with Indinavir (500 mg·kg⁻¹·day⁻¹, oral gavage) for 3 days before the implantation of minipumps that delivered ANG II at 1 μg·kg⁻¹·min⁻¹. Blood pressure was measured in conscious freely moving mice by fluid-filled catheters for three consecutive days beginning 7 days after minipump implantation; n = 7. P < 0.05 vs. control (*) and vs. ANG II (†).